Dose matters for stereotactic body radiotherapy for early stage non-small cell lung cancer

被引：1
|
作者：
Okoye, Christian C. [1 ]
Cho, C. Jane [2 ]
Liu, Mitchell [3 ]
Louie, Alexander V. [4 ]
Obayomi-Davies, Olusola [5 ]
Siva, Shankar [6 ]
Lo, Simon S. [2 ]
机构：
[1] St Bernards Med Ctr, Dept Radiat Oncol, Jonesboro, AR USA
[2] Univ Washington, Sch Med, Dept Radiat Oncol, Seattle, WA USA
[3] BC Canc Vancouver Clin, Vancouver, BC, Canada
[4] Sunnybrook Hlth Sci Ctr, Dept Radiat Oncol, Toronto, ON, Canada
[5] WellStar Med Grp, Dept Radiat Oncol, Marietta, GA USA
[6] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia
来源：
ANNALS OF TRANSLATIONAL MEDICINE | 2020年 / 8卷 / 18期
关键词：
RADIATION-THERAPY; TUMOR-CONTROL; PHASE-II; OUTCOMES; SBRT; TOXICITY; REGIMENS;
D O I：
10.21037/atm-20-3149
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：6
相关论文
共 50 条
  • [41] Dose-effect relationship of stereotactic body radiotherapy in non-small cell lung cancer patients
    Li, Fei
    Jiang, Hairong
    Bu, Mingwei
    Mu, Xin
    Zhao, Hongfu
    RADIATION ONCOLOGY, 2022, 17 (01)
  • [42] A modified formula for dose calculations of stereotactic ablative body radiotherapy for non-small cell lung cancer
    Cao, Yangsen
    Zhu, Xiaofei
    Zhang, Yu
    Yu, Chunshan
    Liu, Yongming
    Sun, Yongjian
    Dai, Zhitao
    Guo, Xueling
    Ju, Xiaoping
    Zhang, Huojun
    MEDICAL DOSIMETRY, 2018, 43 (03) : 207 - 213
  • [43] A phase II study on stereotactic body radiotherapy for stage I non-small cell lung cancer
    Koto, Masashi
    Takai, Yoshihiro
    Ogawa, Yoshihiro
    Matsushita, Haruo
    Takeda, Ken
    Takahashi, Chiaki
    Britton, Keith R.
    Jingu, Kei-ichi
    Takai, Kenji
    Mitsuya, Masatoshi
    Nemoto, Kenji
    Yamada, Shogo
    RADIOTHERAPY AND ONCOLOGY, 2007, 85 (03) : 429 - 434
  • [44] Intensity-modulated stereotactic body radiotherapy for stage I non-small cell lung cancer
    Kim, Min-Jeong
    Yeo, Seung-Gu
    Kim, Eun Seok
    Min, Chul Kee
    Sean, Pyung
    ONCOLOGY LETTERS, 2013, 5 (03) : 840 - 844
  • [45] Stereotactic Body Radiotherapy for Stage I Non-small Cell Lung Cancer Causes Immune Suppression
    Maehata, Y.
    Onishi, H.
    Kuriyama, K.
    Aoki, S.
    Araya, M.
    Saito, R.
    Oguri, M.
    Marino, K.
    Komiyama, T.
    Araki, T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S624 - S624
  • [46] Oncologic Outcomes of Stereotactic Body Radiotherapy in Early-Stage Non-Small Cell Lung Cancer Patients with Interstitial Lung Disease
    Shin, Y. S.
    Song, S. Y.
    Lee, S.
    Choi, E. K.
    Kim, S. S.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S561 - S562
  • [47] Cardiac Dose and Survival After Stereotactic Body Radiotherapy for Early-stage Non-Small-cell Lung Cancer
    Tembhekar, Amode R.
    Wright, Cari L.
    Daly, Megan E.
    CLINICAL LUNG CANCER, 2017, 18 (03) : 293 - 298
  • [48] Outcomes of Patients with Interstitial Lung Disease and Early-Stage Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiotherapy
    Vuong, S.
    Liu, M.
    Wallat, E.
    Bassetti, M. F.
    Baschnagel, A. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E75 - E75
  • [49] Stereotactic Body Radiotherapy for Oligometastatic Disease in Non-small Cell Lung Cancer
    Wujanto, Caryn
    Vellayappan, Balamurugan
    Siva, Shankar
    Louie, Alexander V.
    Guckenberger, Matthias
    Slotman, Ben J.
    Onishi, Hiroshi
    Nagata, Yasushi
    Liu, Mitchell
    Lo, Simon S.
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [50] Stereotactic body radiotherapy for early-stage non-small cell lung cancer in patients with subclinical interstitial lung disease.
    Hu, Min
    Sun, Xiaojiang
    Liu, Yuanjun
    Zhu, Yaoyao
    Xu, Qinghua
    Li, Fangjuan
    Liu, Hui
    Xu, Yaping
    Weng, Denghu
    Lin, Qingren
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345